Description

Prostamax 20mg × 10 vials

A short bioregulatory peptide studied for prostate-related research, cellular regulation, tissue-specific bioregulation, inflammatory response pathways, and age-related prostate function studies.

Product Overview

Compound: Prostamax
Strength: 20 mg per vial
Injection type: Research protocol dependent
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 20 mg
BAC water: 2 mL
Amount per unit: 100 mcg per unit

Research Dose

Protocol dependent.

Notes

Prostamax is described as a short tetrapeptide with the amino acid sequence Lys-Glu-Asp-Pro / KEDP. It has been studied in prostate-related experimental models, including chronic aseptic prostatitis research and tissue-specific bioregulation.

No standard consumer dosing protocol should be assumed. Use only within appropriate research or professional guidance frameworks.

Disclaimer

This product is intended for research and informational purposes only.